Viewing Study NCT04500067


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-02-28 @ 2:29 PM
Study NCT ID: NCT04500067
Status: COMPLETED
Last Update Posted: 2020-10-14
First Post: 2020-07-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment
Sponsor: Biopharma Plasma LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid19 View
None Pneumonia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pneumonia View
None COVID-19 View
None SARS-CoV-2 View
None IVIG View
None Immunoglobulin for Intravenous Administration View
None Bioven View
None Coronavirus View